AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 3 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,439,327 | -3.7% | 1,476,106 | -1.6% | 0.02% | +5.0% |
| Q2 2023 | $3,570,000 | +29.3% | 1,500,000 | 0.0% | 0.02% | +5.3% |
| Q1 2023 | $2,760,000 | -3.2% | 1,500,000 | 0.0% | 0.02% | +46.2% |
| Q4 2022 | $2,850,000 | +225.3% | 1,500,000 | +881.4% | 0.01% | +160.0% |
| Q1 2021 | $876,000 | -19.0% | 152,847 | +126.4% | 0.01% | -58.3% |
| Q2 2020 | $1,082,000 | +52.2% | 67,519 | -43.1% | 0.01% | +50.0% |
| Q1 2020 | $711,000 | -2.6% | 118,734 | +162.0% | 0.01% | +14.3% |
| Q2 2019 | $730,000 | 0.0% | 45,314 | +87.3% | 0.01% | 0.0% |
| Q3 2018 | $730,000 | -63.7% | 24,190 | -67.7% | 0.01% | -56.2% |
| Q2 2018 | $2,009,000 | – | 75,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |